Feng Shu

Feng Shu has a diverse work experience in the fields of research and structural biology. From 2013 to the present, Feng has worked at Chugai Pharmabody Research, starting as a Researcher and progressing to the roles of Senior Researcher, Principal Scientist, and Senior Principal Scientist | Unit Leader. In these positions, Feng led a team in Ab Engineering and lead optimization, successfully delivering several lead Antibodies (Ab) into clinic candidates. Feng also provided suggestions and solutions for Ab format and target antibody profile for different diseases and projects. In 2021, Feng became a Research Manager | Director at Chugai Pharmabody Research.

Prior to joining Chugai Pharmabody Research, Feng worked at Nanyang Technological University as a Postdoc from 2011 to 2013. Here, Feng's work focused on structural biology, including solving co-crystal structures of ribosomes and translation factors. Feng was also involved in training PhD students and played a key role in setting up a newly-established lab.

Feng Shu pursued their education at Nanyang Technological University in Singapore. Feng completed their Bachelor's degree in Biology/Biological Sciences, General from 2002 to 2006. Afterward, they continued their studies at the same university and obtained a Doctor of Philosophy (PhD) degree in Molecular Biology & Genetics and Genomics between 2006 and 2011.